The expression of HB-EGF has been demonstrated in many human cancers, such as hepatocellular carcinoma [18], pancreatic cancer [19], gastric cancer [20,21], colorectal cancer [22], and ovarian cancer [23]. Here, HBEGF is linked to colorectal cancer.